What an IPO grade can and can't do for investors

The grading of an initial public offer (IPO) is a new product, launched in mid-2007 by CRISIL. It is the first time that a product like this has been launched anywhere in the world. It is important for investors to understand

read more | digg story

Sejal Architectural Glass Ltd IPO

Public issue of 91,94,155 equity shares of Rs.10/- each for cash at a price of Rs.[*] per equity share (including share premium of Rs.[*] per share) aggregating Rs.[*] Crores (the issue), by Sejal Architectural Glass Limited (company/issuer). The issue would constitute 32.84% of the fully diluted post issue paid-up equity capital of our company.Pri

read more | digg story

Avon Weighing Systems Ltd IPO

Public issue of 1,37,33,033 Equity Shares of Rs.10/- each of Avon Weighing Systms Ltd (The Company or The Issuer) for cash at par (i.e at a price of Rs.10/- per Share) comprising of Promoters Contribution of 38,96,633 Equity Shares of Face Value of Rs.10/- for cash aggregating to Rs.3.89

read more | digg story

Niraj Cement Structurals IPO Analysis

Niraj Cement Structurals (NCSL) is a small-sizes construction company focusing on the road segment. It also makes pre-cast paver blocks. Sales of paver-blocks account less than 0.5% of total sales. The construction contracts business model involves acting as main contractor, contracts through joint venture (JV)

read more | digg story

Niraj Cement Structurals Ltd IPO

Public issue of 32,50,000 equity shares of Rs.10/- each for cash at a price of Rs.[*] per equity share aggregating Rs.[*] Crores (hereinafter referred to as the issue) by Niraj Cement Structurals Limited (hereinafter referred to as NCSL or the company or the issuer). The issue comprises a reservation for eligible employees of 3,25,000 equity shares

read more | digg story

Bafna Pharmaceuticals Ltd IPO

Public Issue of 64,00,000 equity shares of Rs.10/- each at a price of Rs.40/- per equity share (including share premium of Rs.30/-per equity share) for cash aggregating Rs.25.60 Crores by Bafna Pharmaceuticals Limited (Hereinafter Referred to as the Issue). The issue will constitute 40.05%

read more | digg story

Anus Laboratories Ipo Analysis

Anus Laboratories, Started in Hyderabad in 1996 by K. Hari Babu, Anus Laboratories e manufactures basic and advanced intermediates and fine chemicals. Some of the key intermediates produced are 2,4-dichloro-5-fluoro acetophenone (DCFA) (an intermediate for synthesising quinolone antibiotics like ciprofloxacin),

read more | digg story